Nrf-2 is a redox-sensitive transcription factor that is activated by an oxidative signal in the cytoplasm but has a critical cysteine that must be reduced to bind to DNA in the nucleus. The glutathione (GSH) and thioredoxin (TRX) systems have overlapping functions in thiol/disulfide redox control in both the cytoplasm and the nucleus, and it is unclear whether these are redundant or have unique functions in control of Nrf-2-dependent signaling. To test whether GSH and Trx-1 have distinct functions in Nrf-2 signaling, we selectively modified GSH by metabolic manipulation and selectively modified Trx-1 expression by transient transfection. Cytoplasmic activation of Nrf-2 was measured by its nuclear translocation and nuclear activity of Nrf-2 was measured by expression of a luciferase reporter construct containing an ARE4 from glutamate cysteine ligase. Results showed that tert-butylhydroquinone (TBHQ), a transcriptional activator that functions through Nrf-2/ ARE, promoted Nrf-2 nuclear translocation by a type I (thiylation) redox switch which was regulated by GSH not by Trx-1. In contrast, the ARE reporter was principally controlled by nuclear-targeted Trx-1 and not by GSH. The data show that the GSH and TRX systems have unique, compartmented functions in the control of transcriptional regulation by Nrf-2/ARE.
Gene expression responses to oxidative stress are necessary to ensure cell survival and are largely attributed to specific redoxsensitive transcription factors. Activator protein-1 (AP-1) is a redox-sensitive transcription factor that is responsive to low levels of oxidants resulting in AP-1/DNA binding and an increase in gene expression. AP-1 activation is due to the induction of Jun kinase (JNK) activity by oxidants resulting in the phosphorylation of serine 63 and serine 73 in the c-Jun transactivation domain (Karin, 1995; Smeal et al., 1992) . With high concentrations of oxidants, AP-1 is inhibited and gene expression is impeded. Inhibition of AP-1/DNA interactions is attributed to the oxidation of specific cysteine residues in c-Jun's DNA binding region, namely cysteine 252 (Abate et al., 1990) . Similarly, nuclear factor kappa B (NF-kB), contains a critical cysteine residue (cysteine 62 ) in the p50 subunit that is involved in DNA binding (Matthews et al., 1993) . NF-kB is normally sequestered in the cytoplasm by IkB but under oxidative conditions, IkB is phosphorylated by I-kB kinase (IKK), ubiquitinated and subsequently degraded. Excessive oxidative stress results in the oxidation of cysteine 62 which does not affect its translocation to the nucleus but rather interferes with DNA binding and decreases gene expression (Galter et al., 1994) .
NE-F2 related factor (Nrf-2) is a redox-sensitive transcription factor that has been implicated in cellular responses to oxidative stress. It regulates numerous genes through the antioxidant response element (ARE), such as glutathione synthesis enzymes (Moinova and Mulchahy, 1999; Wild et al., 1998) , thioredoxin-1 (Kim et al., 2003) , heme oxygenase-1 (Inamdar et al., 1996) , glutathione peroxidase, glutathione disulfide reductase (Kwak et al., 2003b) , glutathione S-transferases (Rushmore and Pickett, 1993) , and others. While Nrf-2 is normally sequestered in the cytoplasm by an inhibitor molecule, Keap-1, oxidative stress can stimulate its release and translocation to the nucleus (Nguyen et al., 2003) . Like AP-1 and NF-kB, a cysteine residue (cysteine 506 ) must be in a reduced state for efficient DNA binding to occur (Bloom et al., 2002) . Regulation of Nrf-2 function is controlled by numerous factors, but the dissociation of the Nrf-2/Keap-1 complex is largely a result of the modification of cysteine residues in Keap-1 (cysteine 257, 273, 288, 297 ) in the cytoplasm through either direct conjugation or oxidation (Dinkova-Kostova et al., 2002; Nguyen et al., 2003) .
Two major redox systems, the glutathione (GSH) and thioredoxin (TRX) systems, provide control of intracellular thiol/ disulfide redox environments. Both are ubiquitously distributed among mammalian cell types and function in peroxide elimination, protein thiol/disulfide regulation and as coenzymes. In addition, both are absolutely essential for mammalian life as evidenced by embryonic lethality in GCL and Trx-1 knockout mice (Dalton et al., 2000; Matsui et al., 1996) . Major differences are that GSH is a small peptide present in millimolar concentrations while Trx-1 is a 12 kDa protein present in micromolar concentrations. GSH is a monothiol ideally suited for regulation of protein function involving S-thiylation while Trx-1 contains a conserved dithiol reactive center ideally suited for 2-electron reductions.
However, both GSH and TRX can regulate type I (thiylation) and II (dithiol/disulfide) redox switches, which provide the mechanistic bases for control of the transitions between proliferation, differentiation, and apoptosis (Schafer and Buettner, 2001 ). While there is substantial evidence for overlapping functions of the GSH and TRX systems, evidence shows that their redox potentials are not in equilibrium. For instance, Caco-2 cells undergo a 140 mV oxidation in the GSH/GSSG redox couple during differentiation but the TRX/TRX-SS redox couple is unaffected (Nkabyo et al., 2002) . Due to the lack of rapid redox equilibration between GSH and TRX in cells, each system may regulate independent processes within signal transduction pathways.
Nrf-2 activity is triggered by the dissociation of the Nrf-2/ Kelch-like ECH-associating protein 1 (Keap-1) complex and is controlled by a separate set of cysteine residues (on Keap-1 [cysteine 257, 273, 288, 297 ]) to those residues that regulate DNA binding (cysteine 506 ) (Dinkova-Kostova et al., 2002) . Consequently, compartmentation of Nrf-2 signaling suggests that the GSH and the TRX systems may dictate different steps in the Nrf-2 pathway. GSH is present at high concentrations in the cytoplasm and acts as the major detoxification system during ROS generation, while Trx-1 is better suited for reducing oxidized proteins. In the present study, we used selective modification of the GSH and TRX systems to test whether the cytoplasmic dissociation of Nrf-2 is primarily regulated by cytoplasmic GSH concentrations and the nuclear reduction of Nrf-2 cysteine 506 for DNA binding is primarily regulated by Trx-1. The results show that these two redox control systems function at different sites in the Nrf-2 signaling pathway. Nonequilibrium of the GSH and TRX systems and compartmentation of Nrf-2 signaling thereby provide a mechanism for maintaining the integrity of Nrf-2 signaling, which involved both oxidative and reductive steps, during periods of oxidative stress.
MATERIALS AND METHODS
Cell culture. HeLa cells were purchased from American Type Culture Collection (ATCC, Manassas, VA). Cells were grown in Eagle's Minimum Essential Medium (EMEM) supplemented with 10% Fetal Bovine Serum and antibiotics and maintained in a humidified atmosphere of 5% CO 2 at 37
C. E h calculations for cells were done using the Nernst equation with E o values for pH 7.4 and assuming a 5-ml cell volume per mg of cell protein (Jones, 2002) . Cells were pretreated with 0.5-2 mM N-acetylcysteine (NAC) or 1-100 mM buthionine sulfoximine (BSO) for 24 h. Similarly, for Nrf-2 activation and reporter experiments, cells were treated with 2 mM NAC or 100 mM BSO for 24 h prior to the addition of 50 mM tert-butylhydroquinone (TBHQ), a known activator of Nrf-2, for 6 h.
Glutathione and glutathione disulfide measurement by high performance liquid chromatography (HPLC). GSH and GSSG were assayed by HPLC as S-carboxymethyl, N-dansyl derivatives using g-glutamylglutamate as an internal standard as described by Jones (2002) .
Immunoblot Analysis of Trx-1. HeLa cells were incubated with 2 mM NAC or 100 mM BSO for 24 h after which cells were collected in a cell lysis buffer (350 mM NaCl, 1 mM MgCl 2 , 0.5 mM EDTA, 0.1 mM EGTA, 1% Igepal in 20 mM Hepes [pH 7.5]) containing protein inhibitors (Complete mini-tab, Roche, Indianapolis, IN). Samples were separated by SDS-PAGE on a 12% polyacylamide gel after which they were transferred to a nitrocellulose membrane. Trx-1 was detected with a goat primary antibody raised against human Trx-1 (American Diagnostica, Greenwich, CT) and with an AlexaFluor 680 nm anti-goat IgG secondary antibody (Molecular Probes, Eugene, OR). Membranes were scanned with an Odyssey fluorescence scanner (Li-Cor, Lincoln, NE). Densitometric analysis was performed with the Odyssey scanning software.
Redox Western. Redox Western analysis of Trx-1 redox state was slightly modified from the original protocol as described by . Trx-1 was carboxymethylated in guanidine-Tris solution (6 M guanidine-HCl, 50 mM Tris, pH 8.3, 3 mM EDTA, 0.5% (v/v) Triton X-100) containing 50 mM iodoacetic acid (IAA) and incubated for 30 min at 37 C. Excess IAA was removed by Sephadex chromatography (MicroSpin G-25 columns, Amersham Biosciences) after which samples were diluted in 53 nonreducing sample buffer (0.1 M TrisHCl, pH 6.8, 50% (v/v) glycerol, 0.05% (w/v) bromophenol blue) and separated on a discontinuous native polyacrylamide gel (5% stacking gel, 15% resolving gel). Gels were electroblotted to polyvinylidene difluoride membrane and probed for Trx1 using anti-Trx1 primary antibody (American Diagnostica, Greenwich, CT) and AlexaFluor 680 nm anti-goat IgG secondary antibody (Molecular Probes, Eugene, OR). Membranes were scanned with an Odyssey fluorescence scanner (Li-Cor, Lincoln, NE). Densitometric analysis was performed with the Odyssey scanning software. Redox potentials were determined using band intensities and the Nernst equation
Nrf-2 localization. Nuclear and cytoplasmic isolates were collected with the TransFactor Extraction kit (Clontech, Palo Alto, CA). Nrf-2 localization in the nucleus was determined by SDS-PAGE (12% polyacrylamide) analysis using a goat Nrf-2 antibody for primary detection (Santa Cruz Biotechnology, Santa Cruz, CA). A donkey anti-goat AlexaFluor 680 IgG antibody (Molecular Probes, Eugene, OR) was used for secondary detection. Membranes were subsequently scanned by an Odyssey fluorescence scanner (Li-Cor, Lincoln, NE). Densitometry was quantified by the Odyssey scanning software.
Expression vector transfections. Cells were grown until they reached $70% confluence. All transfections were performed using Fugene6 transfection reagent (Roche, Indianapolis, IN) per the manufacturer's instructions. Plasmid pcDNA3.1 encoding human Trx-1 was a kind gift from Dr. Jiyang Cai of Vanderbilt University. The nuclear-targeted Trx-1 was sublconed into pcDNA3.1 encoding C35S Trx-1 and wild-type Trx-1 containing the SV40 T-antigen nuclear localization sequence (PPKKKRKVEDP). Site-directed mutagenesis was performed on the Trx-1-NLS construct to introduce the C35S mutation into the active site by Gene Tailor site-directed mutagenesis kit (Invitrogen). The C35S Trx-1-NLS mutant was generated by hybridization of the plasmid with oligonucleotides of the sequence 5 0 -CCACGTGGCTGAGAAGTCAACTATA-CAAGT-3 0 and 5 0 -TTGACTTCTCAGCCACTGGGTGTGGGCCTTCA-3 0 , respectively. Clones containing the desired mutations were selected and verified by DNA sequencing. The ARE4-luciferase reporter construct was a kind gift from Dr. Jerry J. Gipp (University of Wisconsin, Madison, WI). Luciferase and b-galactosidase enzyme assays were measured as described previously (Go et al., 2004) . Luciferase measurements were normalized to b-galactosidase activity as determined with the b-galactosidase enzyme assay kit under conditions outlined by the manufacturer (Promega, Madison, WI).
Statistical analysis. Each measurement is the result of three independently performed experiments. The one-way analysis of variance (ANOVA) was employed to determine whether the means of different groups were significantly different. The Tukey's post-hoc test was used to determine the significance for all pairwise comparisons of interest. To evaluate redox equilibration between GSH and Trx-1 in HeLa cells, cultures were treated with GSH modulating agents, NAC, to increase intracellular GSH, and BSO, to decrease GSH. NAC treatments (0.5-2 mM) for 24 h increased GSH concentrations at the highest treatment (2 mM) where concentrations were increased by approximately 15% from control GSH concentrations (Fig. 1) . No significant changes in GSSG concentrations were detected. Similarly, no significant changes were seen in GSH/GSSG redox potential, ranging from À256 to À260 mV. Using BSO (1-100 mM) for 24 h, GSH was decreased in a dosedependent manner, where GSH changes ranged from decreases of 15% (1 mM) to 85% (100 mM) of control GSH concentrations. A 15% increase in GSSG concentrations was noted with the lowest BSO concentration and subsequently higher BSO doses decreased GSSG concentrations. Together these changes in GSH and GSSG concentrations produced a dose-dependent increase in redox potential, increasing maximally by 130 mV at 100 mM BSO.
Redox Western blot analysis of reduced (Trx-1
SH2
) and oxidized (Trx-1 SS ) showed no changes in Trx-1 redox state with either NAC or BSO ( Figs. 2A and 2B) , where values ranged from À287 (64) to À282 (64) mV. These results show that the GSH redox state is independent of Trx-1 levels.
FIG. 1. (A)
Changes in GSH and GSSG concentrations, (B) changes in GSH/GSSG redox potential (E h ), and (C) changes in GSH:GSSG ratios as compared to control levels following treatment with either 0.5-2.0 mM NAC or 1-100 mM BSO for 24 h. Control GSH concentrations measured 4.6 (60.4) mM. Control GSSG measured 0.04 (60.004) mM. Data is shown as percent changes from control and is representative of four independently performed experiments. Asterisks (*) denote a significant difference (p 5 0.05) from control.
Although the ratio of reduced:oxidized Trx-1 did not correlate with changes in GSH and GSSG concentrations or redox potential, BSO treatment, but not NAC treatments, caused an increase in the total amount of Trx-1 over a 24 h period (Figs. 2C and 2D) . Immunoblot analysis confirmed an overall increase in Trx-1 protein, up to 212% of control, following GSH depletion via BSO. These changes in total Trx-1 protein are consistent with an activation of the antioxidant response element as the Trx-1 gene is controlled by this element (Kim et al., 2003) . and related mutants did not have any significant effect on GSH redox state or GSH concentration. (Figs. 3A and 3C) . After 48 h of transient transfection with the various Trx-1 expression plasmids, GSH/GSSG redox potential ranged from À257 (64) to À261 (65) mV and were not different (Fig. 3) . Together with the above data, these results show that the GSH and TRX redox states are independently controlled and that BSO and transient transfection with Trx-1 and Trx-1 mutants provide an approach to evaluate selective functions of the two systems.
TBHQ Alters GSH but Not Trx-1
Tert-butylhydroquinone (TBHQ), a potent activator of the Nrf-2 pathway, is believed to generate reactive oxygen species through a redox cycling mechanism which in turn initiates Nrf-2 dissociation (Nguyen et al., 2003) . To evaluate the effects of TBHQ on GSH, cultures were pretreated with either 2 mM NAC or 100 mM BSO for 24 h and then treated with 50 mM TBHQ for 6 h. TBHQ in cultures not receiving any pretreatment caused an increase in GSH and GSSG concentrations (Figs. 4A and 4B). In NAC and BSO pretreated cells, TBHQ similarly increased both GSH and GSSG concentrations. With TBHQ co-treatment, NAC or BSO pretreatments produced no significant differences in redox potential as compared to cultures treated with NAC or BSO only (Fig. 4C) . However, notable changes in GSH:GSSG ratios were evident with TBHQ treatment. NAC co-treated with TBHQ caused a significant decrease in the GSH:GSSG ratio, while BSO co-treated with TBHQ had the opposite effect resulting in an increase (Fig. 4D) . Thus, the data are consistent with an upregulation in GSH synthesis that is coupled with oxidation of GSH to GSSG. In contrast to changes in GSH redox state, TBHQ (0-50 mM) did not alter the Trx-1 redox state (Figs. 5A and 5B). The failure of TBHQ to alter Trx-1 redox state further supports that the regulation of TBHQ-induced Nrf-2 dissociation involves GSH and not Trx-1.
GSH/GSSG Ratio Controls Cytoplasmic Nrf-2 Dissociation/ Nuclear Translocation
The ability to independently control the GSH and TRX systems allowed us to test whether cytoplasmic dissociation/ nuclear translocation of Nrf-2 was controlled by one or both of these systems. Results showed that depletion of GSH with BSO increased cytoplasmic dissociation/nuclear translocation of Nrf-2 while pretreatment with NAC decreased this process (Fig. 6A) . In contrast, increased expression of Trx-1 by transfection had no effect on Nrf-2 cytoplasmic dissociation/nuclear translocation (Fig. 6B) .
Using TBHQ as an Nrf-2 stimulator, results showed that TBHQ-induced cytoplasmic dissociation/nuclear translocation is a process that was blocked by NAC (Fig. 6A) but not by Trx-1 overexpression (Fig. 6B) . Under these conditions, NAC prevented TBHQ-induced changes in GSH/GSSG ratios but did not change E h GSH/GSSG (Fig. 4) . Consequently, the data show cytoplasmic dissociation/nuclear translocation of Nrf-2 is controlled by GSH and not Trx-1. Furthermore, because type I thiol switches respond to changes in GSH/GSSG ratios while type II thiol switches respond to changes in E h (Gilbert, 1990; Schafer and Beuttner, 2001) , the data are consistent with regulation by a type I redox switch and not consistent with a type II switch.
Oxidation of GSH/GSSG Is Associated with Nuclear
Activation of the ARE To measure nuclear activity of Nrf-2, HeLa cells were transiently transfected with the ARE4-L reporter construct. Modulation of total GSH concentrations was achieved via 24 h incubation with either 2 mM NAC or 100 mM BSO and then treated with or without TBHQ for 6 h as described above. The expression of the reporter increased with TBHQ treatment only (Fig. 7) . Expression of the reporter was increased by BSO and decreased by NAC pretreatment. As expected, TBHQ increased expression of the reporter. Furthermore, BSO increased and NAC decreased TBHQ-induced expression. Because these changes in transcriptional activity so completely paralleled the nuclear translocation of Nrf-2, the results provide evidence for GSH/GSSG control solely in the cytoplasmic compartment and provide no evidence for function of GSH in the nuclear regulation of Nrf-2 binding to the ARE. In vitro studies show that Trx-1 functions in the reduction of cysteine residues critical for transcription factor binding to DNA (Hirota et al., 1997; Makino et al., 1999; Matthews et al., 1993) . Because overexpression of Trx-1 had no effect on cytoplasmic dissociation of Nrf-2, co-transfection of Trx-1 along with the ARE4 reporter provided an opportunity to determine whether Trx-1 functions in the Nrf-2 activation of the ARE. Trx-1 overexpression caused a significant increase in ARE activation as determined by luciferase activity but Trx-1 active site mutant, C35S Trx-1, inhibited ARE activation (Fig. 8) . TBHQ induction of Nrf-2 activity only occurred with wild-type Trx-1 overexpession but Nrf-2 activity was inhibited by C35S Trx-1. Consequently, the data show that Trx-1 functions in transcriptional activation but not in nuclear translocation, as expected from the previous characterized reduction of the cysteine in the DNA binding site (Bloom et al., 2002) .
To further test whether this occurred in the nuclei, we used a nuclear targeted fusion protein created with a SV-40 nuclear translocation sequence complexed to Trx-1 (NLS-Trx-1). Transfection with NLS-Trx-1 showed an even greater increase in Nrf-2/ARE activity than with wild-type Trx-1 (Fig. 8) . Overexpression of NLS-C35S Trx-1 mutant decreased Nrf-2/ARE activity and appeared to have similar effects as the C35S Trx-1 mutant (Fig. 8) . TBHQ treatment increased Nrf-2/ARE activity overexpressing NLS-Trx-1 but decreased in cells transfected with the NLS-C35S Trx-1 mutant. Because Trx-1 overexpression had no effect on Nrf-2 dissociation/nuclear translocation (Fig. 6 ) it is clear that nuclear Trx-1 plays a distinct role downstream of the cytoplasmic Nrf-2 dissociation/nuclear translocation events, namely Trx-1 regulates Nrf-2 at the DNA interaction level.
DISCUSSION
Accumulating evidence has shown nonequilibrium between the GSH and TRX systems but, as a result, has not demonstrated independent regulation of specific redox-sensitive signal transduction pathways. In the present study, we establish the independence of these two redox systems in Nrf-2 signaling. Two redox-sensitive steps comprise Nrf-2 signaling: the dissociation of the Nrf-2/Keap-1 complex in the cytoplasm and the binding of Nrf-2 to the ARE in the nucleus. Nrf-2 can be activated by oxidants, and consequently, antioxidants, such as ascorbic acid, decrease Nrf-2 activity (Tarumoto et al., 2004) . GSH is an abundant antioxidant in cells (Cotgreave and Gerdes, 1998) and is responsible for the regulating of oxidative signals that initiate Nrf-2 dissociation. Decreased GSH concentrations and/or a shift in GSH/GSSG ratios may permit Nrf-2/Keap-1 dissociation. GSH depletion via BSO resulted in Nrf-2 nuclear translocation even without TBHQ stimulation but NAC supplementation, which increased GSH concentrations, inhibited translocation even with TBHQ stimulation. Overexpression of Trx-1 did not alter the movement of Nrf-2 to the nucleus during TBHQ stimulation. These results demonstrate that GSH concentration and/or GSH/GSSG ratios, but not necessarily GSH redox potential, are key determinants in Nrf-2/Keap-1 dissociation and Nrf-2 translocation to the nucleus. GSH inhibition of dissociation and translocation may result from the ability of GSH to actively detoxify Nrf-2/Keap-1 dissociation signals (i.e., ROS). Moreover, these results suggest that regulation of this process may rely more on a type I redox switch and are dependent upon thiylation rather than disulfide formation (Gilbert, 1995; Schafer and Buettner, 2001 ). On the other hand, Trx-1 has little effect on the early events of Nrf-2 dissociation but Trx-1 overexpression increases activation of the ARE. This finding is consistent with the reduction of the critical cysteine in the DNA binding site (Bloom et al., 2002) . Mutant Trx-1 does not show the same increase but rather a substantial decrease compared to control levels of ARE activation. Because overexpression of Trx-1 did not cause a decrease in Nrf-2 dissociation/nuclear translocation the data further show that Trx-1 function is limited to the Nrf-2/ DNA binding aspect of Nrf-2 signaling. Oxidative stress may activate Nrf-2 but an oxidative environment would promote a decline in Nrf-2/DNA binding in the nucleus. Utilizing nuclear-targeted Trx-1, ARE activation increased significantly from the overexpression of non-targeted, wild-type Trx-1, while the nuclear-targeted mutant Trx-1 inhibited ARE activation. Consequently, the data show that the nuclear activity of Nrf-2 depends upon nuclear Trx-1. This observation may be of fundamental importance because it suggests that the Nrf-2 cysteine in the DNA binding domain is not fully reduced under these conditions. This implies that the cysteines of DNA binding sites of transcription factors may function as redox switches, and are not merely ''critical'' cysteines but rather may provide some regulatory functions as well. Many transcription factors have such cysteines (e.g., NF-kB, p53, Fos, Jun, glucocorticoid receptor, etc.). Indeed, transfection with a wild-type Trx-1 produced an increase in NF-kB activity determined by various reporter constructs, but transfection with a plasmid for nuclear-targeted Trx-1 potentiated NF-kB activity as compared to transfection with wild-type Trx-1 plasmids Kontou et al., 2003) . With Nrf-2, activation, dissociation, nuclear transport, and DNA binding is a multi-step process. From our findings, there is a redox component which includes both the GSH and TRX systems. While incomplete, involvement of these systems furthers our understanding of Nrf-2 signaling.
Compartmentation of specific Nrf-2 events appears to be dependent upon the concentration of GSH in the cytoplasm and Trx-1 in the nucleus. Much study has focused on compartmentation of GSH, especially between the cytoplasm and nucleus, but due to pores in the nuclear envelope, it is difficult to measure nuclear GSH concentrations by traditional chromatography methods. Still, some studies have concluded that there are higher concentrations of GSH in the nucleus vs. the cytoplasm using fluorescent dyes (Bellomo et al., 1992; Voehringer et al., 1998) , while others arrive at opposing conclusions using GSH antibodies (Cotgreave, 2003) . Trx-1 is much larger and is not freely permeable across the nuclear envelope, allowing measurement in the nucleus (i.e., via Redox Western analysis) . Evidence supports differences in nuclear and cytoplasmic Trx-1 pools and a mechanism for nuclear sequestration of Trx-1 during oxidative stress .
Nrf-2 is a critical component in the response to oxidative stress and upregulates multiple genes to ensure cell survival (Kwak et al., 2003a) . Cell models have illustrated changes in GSH redox potential with proliferation and differentiation (Hutter et al., 1997; Kirlin et al., 1999; Nkabyo et al., 2002) . In combination with the results in the present study, one may speculate that proliferating cells would be less likely to activate Nrf-2 due to higher concentrations of GSH and a lower redox potential (40-60 mV more reduced). Conversely, differentiated cells that contain less GSH would be prone to activate the Nrf-2 pathway even with a milder oxidative signal. Embryonic development is composed of multiple subpopulations of proliferating and differentiating cells, which have different GSH redox potentials and regulate different redox-sensitive transcription factors. Measurements of GSH, cysteine, and Trx-1 concentrations in early organogenesis stage rat and rabbit embryo limbs, trunks, and head regions showed marked differences in GSH concentrations, GSSG concentrations, and GSH/GSSG redox potentials (Hansen et al., 2001) , and recent studies have shown stem cell totipotentiality and blastocyst differentiation are regulated by the activity of the redox-sensitive transcription factor Oct-4 (Guo et al., 2004) . Because redox mechanisms control both differentiation (Oct-4) and detoxification (Nrf-2) cellular protection may vary in proliferating and differentiating cells, where proliferating cells (with higher GSH concentrations and GSH/GSSG ratios) may not activate Nrf-2 are readily as differentiating cells. This has important implications for developmental toxicity where disruption of redox control can substantially alter gene expression patterns and result in teratogenesis.
In summary, the present data show that oxidant-induced Nrf-2 dissociation in the cytoplasm is controlled by GSH while DNA interactions are controlled by nuclear Trx-1. Thus, even though the GSH and TRX systems have overlapping activities, compartmentation and specificity of interactions allow distinct roles in Nrf-2 signaling. Activation in response to an oxidant signal can occur in the cytoplasm and is dependent upon the GSH system, while nuclear Trx-1 maintains the Nrf-2 signal by reducing critical cysteines in the DNA binding domain. With tandem, complementary functions, GSH and Trx-1 regulate Nrf-2 activity for proper responses to oxidative insult.
